The Restriction of Hazardous Substances (RoHS) directive is often associated with electronic products, but its implications extend to medical devices and surgical instruments as well. For Southeast Asian manufacturers selling on Alibaba.com, understanding RoHS requirements is essential for accessing European, North American, and other regulated markets.
What RoHS Actually Restricts
RoHS limits ten hazardous substances in electrical and electronic equipment (EEE), including medical devices classified under Categories 8 and 9. The restricted substances and their maximum concentration values are:
Medical Device Coverage Under RoHS
Medical devices have been subject to RoHS II requirements since July 22, 2014, with in vitro diagnostic (IVD) devices included from July 22, 2016. This means surgical instruments, monitoring equipment, and other medical EEE must comply with substance restrictions unless specific exemptions apply [2].
Critical 2026 Regulatory Changes
Several significant regulatory updates take effect in 2026 that directly impact medical device manufacturers:
• Directive (EU) 2025/2456 entered into force on January 1, 2026, introducing updated compliance procedures • August 13, 2027: The European Chemicals Agency (ECHA) will take over exemption application processing from the European Commission • Omnibus IV Proposal: Digital product passports and electronic documentation will become standard for compliance verification • EN IEC 63000 Standard: Technical documentation requirements are under revision, expected completion by 2028 [1]
The regulatory landscape is shifting toward digital compliance documentation. Manufacturers should prepare for electronic product passport integration and automated conformity assessment processes [1].

